CoLucid Pharmaceuticals, Inc. to Attend the BIO-Europe 2012 Meeting in Hamburg, Germany

Published: Nov 08, 2012

DURHAM, N.C.--(BUSINESS WIRE)--CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced today that Thomas P. Mathers, Chief Executive Officer, will be attending the 18th Annual International Partnering Conference held at the CCH Congress Center in Hamburg, Germany from November 12-14, 2012. Mr. Mathers, along with Linda Hogan, Vice President of Business Development, will be meeting with potential partners to discuss the most recent clinical and regulatory milestones achieved by CoLucid for lasmiditan as well as highlights from recently completed market research.

Back to news